Investors Presentation on the Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported a challenging Q4FY26 with revenue of ₹3,438 Cr (down 2% YoY) and EBITDA of ₹274 Cr (down 16% YoY), impacted by lower soda ash realisations across geographies. The company took a significant ₹1,837 Cr goodwill impairment charge in its US operations due to current soda ash market conditions. Full year FY26 revenue stood at ₹14,584 Cr with EBITDA of ₹1,805 Cr, both declining approximately 2-8% from FY25. Despite headwinds, positive highlights include 14% growth in non-soda ash revenue to ₹6,946 Cr, successful completion of the Novabay pharma-grade bicarb acquisition in Singapore, and reaching 1 MTPA soda ash production milestone at Mithapur. The board recommended a dividend of ₹11 per share. Net debt increased to ₹5,961 Cr mainly due to ₹460 Cr forex impact.
The substantial impairment charge and margin pressure from lower soda ash prices signal near-term earnings challenges. However, the company's focus on diversifying into non-cyclical businesses and its low leverage (debt-to-equity of 0.36) provide some comfort for long-term investors.